国药科技股份（股票代码：08156）于2026年5月5日披露了截至2026年4月30日止当月的股份变动月报。公司注册股本维持在2.00亿港元，其中普通股法定数额为1.60亿港元，优先股法定数额为4000万港元，均与上月保持一致。
公司普通股本月底已发行股份总数为633,693,055股，较上月底无新增或减少；可换股优先股已发行股份总数为1,480,151,050股，亦无变化。公司当月未发生股份发行、购回或注销，股本结构保持稳定。
在股权激励方面，2021购股权计划中共有120,000份购股权于当月失效，余下4,960,000份购股权；当月未因行使该等购股权而新增发行股份。公司同时报告已发行可换股优先股的总额为148,015,105港元，未见变动。
公司确认截至4月末公共持股量符合香港联合交易所有限公司相关上市规则及适用法律要求。公告由公司执行董事郭淑儀签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.